Cynosure Lutronic Executive and Leadership Team

Nadav Tomer, the Chief Executive Officer at Cynosure Lutronic, directs the global strategic vision for energy-based aesthetic and medical treatment systems. Overseeing the entire product portfolio, the Chief Executive Officer ensures alignment between research development and market demands for hair removal and skin revitalization technologies. This leadership role involves driving international expansion across diverse medical markets while maintaining rigorous quality standards for all manufacturing processes. By fostering collaboration among cross-functional teams, Nadav Tomer accelerates the delivery of cutting-edge treatment applications to physicians and aesthetic business owners. The Chief Executive Officer maintains a focus on long-term growth, ensuring the company remains at the forefront of the medical device industry. Through consistent evaluation of market trends, the Chief Executive Officer optimizes the organizational structure to support scalable innovation and sustained competitive advantage in the global aesthetic landscape.

Timothy Gehlmann, the Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc at Cynosure Lutronic, manages the specialized photonics integration within the broader aesthetic treatment ecosystem. Focusing on the technical architecture of energy-based systems, the Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc drives the development of advanced light-based technologies for scar reduction and gynecological health. This role requires close coordination with engineering departments to refine the precision of medical devices used by practitioners globally. By overseeing the technical roadmap, Timothy Gehlmann ensures that the company maintains a technological edge in the competitive medical manufacturing sector. The Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc facilitates the transition from laboratory innovation to commercialized medical products, supporting the overall mission of enhancing patient outcomes through superior engineering and reliable, high-performance hardware solutions.

Cyriacus Njoku, the Chief Executive Officer & President at Cynosure Lutronic, leads the commercial execution and market penetration strategies for the company's diverse range of aesthetic treatment systems. Tasked with expanding the footprint of body contouring and skin revitalization platforms, the Chief Executive Officer & President oversees regional sales initiatives and practitioner engagement programs. This leadership position involves building strong relationships with medical professionals to ensure the effective adoption of new treatment modalities. By analyzing regional market performance, Cyriacus Njoku identifies opportunities for growth and service enhancement across international territories. The Chief Executive Officer & President coordinates with the executive team to align commercial goals with the company's broader manufacturing capabilities. Through strategic oversight of the sales pipeline, the Chief Executive Officer & President secures the company's position as a preferred partner for aesthetic business owners seeking the latest, most effective medical treatment technologies.

Bob Howe, the Chief Financial Officer at Cynosure Lutronic, manages the fiscal health and capital allocation strategies necessary to support the development of energy-based medical systems. Overseeing financial planning, reporting, and risk management, the Chief Financial Officer ensures the company maintains the resources required for continuous innovation in hair removal and skin revitalization technologies. This role involves providing data-driven insights to the board to guide investment in new manufacturing capabilities and market expansion. By optimizing the cost structure and monitoring global financial performance, Bob Howe supports the company's ability to deliver high-quality aesthetic solutions to practitioners worldwide. The Chief Financial Officer maintains rigorous oversight of financial controls, ensuring transparency and compliance across all business units. Through disciplined financial management, the Chief Financial Officer enables the organization to pursue long-term growth objectives while navigating the complexities of the global medical device market.

Baker Baker, the Executive Vice President & Chief Financial Officer at Cynosure Lutronic, directs the long-term financial strategy and corporate development initiatives. Focusing on capital structure and investment efficiency, the Executive Vice President & Chief Financial Officer evaluates the financial viability of new product lines, including body contouring and gynecological health systems. This role involves managing investor relations and ensuring the company's financial narrative aligns with its mission of providing best-in-class aesthetic treatments. By overseeing treasury functions and financial forecasting, Baker Baker provides the stability needed for the company to scale its manufacturing operations. The Executive Vice President & Chief Financial Officer collaborates with other leaders to prioritize resource allocation toward high-growth market segments. Through strategic financial planning, the Executive Vice President & Chief Financial Officer strengthens the company's balance sheet, ensuring the organization remains well-positioned to lead the medical aesthetic industry through periods of rapid technological change.

Jae Yoo, the Chief Operations Officer at Cynosure Lutronic, oversees the end-to-end manufacturing and supply chain processes for all energy-based aesthetic treatment systems. Tasked with ensuring operational excellence, the Chief Operations Officer manages the production of devices for hair removal, scar reduction, and skin revitalization. This role involves streamlining logistics and quality control to meet the high demands of practitioners and physicians globally. By implementing lean manufacturing principles, Jae Yoo improves efficiency and reduces lead times for critical medical equipment. The Chief Operations Officer coordinates with research and development teams to ensure that new product designs are scalable and ready for mass production. Through rigorous oversight of the supply chain, the Chief Operations Officer maintains the availability of essential components, supporting the company's ability to deliver consistent, high-quality treatment solutions to the global aesthetic market.

Sean Flanagan, the Chief Legal Officer at Cynosure Lutronic, directs the legal strategy and regulatory compliance framework for the company's diverse portfolio of medical treatment systems. Overseeing intellectual property protection and global regulatory filings, the Chief Legal Officer ensures that all products, including those for body contouring and gynecological health, meet stringent international safety standards. This role involves managing complex legal risks and providing guidance on corporate governance to the executive team. By navigating the regulatory landscape, Sean Flanagan enables the company to bring innovative aesthetic technologies to market with confidence. The Chief Legal Officer collaborates with the board to address legal challenges and protect the company's competitive position in the medical device industry. Through proactive legal management, the Chief Legal Officer safeguards the organization's reputation and ensures that all business operations adhere to the highest ethical and legal requirements.